These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2530767)

  • 1. An interim overview of the safety and tolerability of paroxetine.
    Dunbar GC
    Acta Psychiatr Scand Suppl; 1989; 350():135-7. PubMed ID: 2530767
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H; Rudolf GA
    Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773
    [No Abstract]   [Full Text] [Related]  

  • 3. Antidepressants and the peripheral nervous system.
    Husstedt IW; Kuhs H; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():147-8. PubMed ID: 2530774
    [No Abstract]   [Full Text] [Related]  

  • 4. An overview of paroxetine.
    Boyer WF; Feighner JP
    J Clin Psychiatry; 1992 Feb; 53 Suppl():3-6. PubMed ID: 1531819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic.
    Miller SM; Naylor GJ; Murtagh M; Winslow G
    Acta Psychiatr Scand Suppl; 1989; 350():143-4. PubMed ID: 2530772
    [No Abstract]   [Full Text] [Related]  

  • 6. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
    Tasker TC; Kaye CM; Zussman BD; Link CG
    Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients.
    Guillibert E; Pelicier Y; Archambault JC; Chabannes JP; Clerc G; Desvilles M; Guibert M; Pagot R; Poisat JL; Thobie Y
    Acta Psychiatr Scand Suppl; 1989; 350():132-4. PubMed ID: 2530766
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic hepatitis due to femoxetine.
    Aunsholt NA; Agnholt J
    Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):253-4. PubMed ID: 3716819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1990 Apr; 18(4):289-99. PubMed ID: 2140382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical pharmacology of paroxetine in healthy subjects.
    Raptopoulos P; McClelland GR; Jackson D
    Acta Psychiatr Scand Suppl; 1989; 350():46-8. PubMed ID: 2530788
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
    Bascara L
    Acta Psychiatr Scand Suppl; 1989; 350():141-2. PubMed ID: 2530771
    [No Abstract]   [Full Text] [Related]  

  • 14. Depression and selective serotonin reuptake inhibitors.
    Westwick F
    Br J Hosp Med; 1990 Nov; 44(5):367. PubMed ID: 2148896
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of paroxetine on the quantitative EEG.
    McClelland GR; Raptopoulos P; Jackson D
    Acta Psychiatr Scand Suppl; 1989; 350():50-2. PubMed ID: 2530790
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacokinetics of paroxetine in renal impairment.
    Doyle GD; Laher M; Kelly JG; Byrne MM; Clarkson A; Zussman BD
    Acta Psychiatr Scand Suppl; 1989; 350():89-90. PubMed ID: 2530798
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacokinetics of paroxetine in elderly depressed patients.
    Ghose K
    Acta Psychiatr Scand Suppl; 1989; 350():87-8. PubMed ID: 2530797
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, multicentre study of paroxetine and mianserin in depression.
    Mertens C; Pintens H
    Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure.
    Edwards JG; Goldie A; Papayanni-Papasthatis S; Punter J; Sedgwick EM
    Acta Psychiatr Scand Suppl; 1989; 350():124. PubMed ID: 2530762
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption of paroxetine under various dietary conditions and following antacid intake.
    Greb WH; Brett MA; Buscher G; Dierdorf HD; von Schrader HW; Wolf D; Mellows G; Zussman BD
    Acta Psychiatr Scand Suppl; 1989; 350():99-101. PubMed ID: 2530802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.